XML 31 R19.htm IDEA: XBRL DOCUMENT v3.25.3
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES: Fair Value of Financial Instruments (Policies)
9 Months Ended
Sep. 30, 2025
Policies  
Fair Value of Financial Instruments

Fair Value of Financial Instruments

 

Fair value is defined as a market-based measurement intended to estimate the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date under current market conditions. The Financial Accounting Standard Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 820, Fair Value Measurement (“ASC 820”), defines fair value and guides on how to measure it. ASC 820 outlines required disclosures and describes valuation techniques, including the market approach (using comparable market prices), the income approach (present value of future income or cash flows), and the cost approach (replacement cost of an asset’s service capacity). ASC 820 also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs when measuring fair value. These inputs are categorized as follows:

 

·Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities. 

·Level 2: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active. 

·Level 3: Unobservable inputs that reflect the reporting entity‘s own assumptions. 

 

The carrying values of cash equivalents, accounts receivable, and accounts payable approximate fair value due to their short-term nature. The estimated fair value of our long-term debt approximates its carrying value upon our expected borrowing rate for debt with similar remaining maturities and comparable risk (level 2). The Company currently has no financial instruments measured at estimated fair value on a recurring basis based on the valuation reports provided by the counterparties.